✦ LIBER ✦

The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with stage I/favorable histology Wilms' tumor. A report from the National Wilms' Tumor Study

✍ Scribed by Daniel M. Green; J. Bruce Beckwith; Douglas A. Weeks; Jami Moksness; Norman E. Breslow; Giulio J. D'Angio

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 381 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940915)74:6<1817::aid-cncr2820740626>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of children with stage IV favo

Treatment of children with stage IV favorable histology Wilms tumor: A report from the National Wilms Tumor Study Group

✍ Green, Daniel M.; Breslow, Norman E.; Evans, Ilonka; Moksness, Jami; D'Angio, Gi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D o n the relapse-free survival of children with stage IV/favorable histology Wilms tumor. We reviewed the clinical courses of all ran

Radiotherapy omitted in the treatment of

Radiotherapy omitted in the treatment of selected children under 3 years of age with stage III favorable histology Wilms tumor

✍ Pachnis, A.; Pritchard, J.; Gaze, M.; Levitt, G.; Michalski, A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

Background. Current treatment of stage III favorable histology (FH) Wilms tumor is surgery, radiotherapy to residual disease, and ''triple'' chemotherapy (vincristine, dactinomycin, and doxorubicin) for 12 months. This study tests the hypothesis that some stage III patients, especially very young ch